Hers Alternatives: The Best Options for Weight Loss, HRT, Hair, and Mental Health in 2026

Is Hers Legit? A Clinical Assessment

Hers operates as a licensed telehealth platform that connects patients with prescribers in their state. The company is real, the prescriptions are valid, and its affiliated pharmacies hold state and federal registrations. That much is not in dispute.

The clinical question is whether an async, subscription-first model provides the same quality of care as a physician-led, visit-based approach. A 2023 cross-sectional study published in JAMA Network Open found that direct-to-consumer telehealth platforms prescribed medications in 65% of encounters, often after visits lasting fewer than five minutes [1]. The American Medical Association has noted that "asynchronous telehealth encounters may not provide the same opportunity for shared decision-making as synchronous visits" [2]. For low-complexity refills (topical minoxidil, established SSRI doses), async models work well. For hormone titration or GLP-1 dose escalation, the gap in clinical oversight becomes meaningful.

Hers reviews on Trustpilot and the BBB cluster around two themes: fast prescription turnaround (positive) and difficulty reaching a provider for dose adjustments or side-effect management (negative). The platform is legit. Whether it is the best option depends entirely on the clinical complexity of what you need.

Weight Loss: Hers vs. Alternatives

Hers entered the weight-loss market with compounded semaglutide, priced between $149 and $199 per month. Its formulary does not include brand-name Wegovy or tirzepatide (Zepbound), limiting options for patients who need FDA-approved formulations or dual-agonist therapy.

In the STEP 1 trial (N=1,961), subcutaneous semaglutide 2.4 mg produced 14.9% mean total body weight loss at 68 weeks versus 2.4% with placebo [3]. The SURMOUNT-1 trial (N=2,539) demonstrated that tirzepatide 15 mg achieved 22.5% weight loss at 72 weeks [4]. Access to both drug classes matters because patient response varies. A 2024 retrospective analysis in Obesity found that approximately 15% of patients who plateaued on semaglutide achieved additional weight loss after switching to tirzepatide [5].

Best alternatives for weight loss:

• HealthRX offers both compounded and brand-name semaglutide alongside tirzepatide, with physician-led titration visits and lab monitoring. Monthly pricing starts at $149 for compounded formulations.
• Ro provides brand-name Wegovy and compounded semaglutide with metabolic lab panels included. Pricing is competitive at $145 to $399/month depending on the formulation.
• Found uses a behavioral-pharmacotherapy model pairing medications with coaching, though its GLP-1 access can be limited by insurance routing.

The deciding factor is formulary breadth. If you respond well to compounded semaglutide and want the lowest price, Hers works. If you may need tirzepatide, brand-name options, or structured dose escalation with lab work, a platform with a wider formulary and synchronous physician visits is the stronger choice.

Women's HRT: Where Hers Falls Short

Hers offers estradiol patches and oral progesterone for perimenopausal and postmenopausal women. The formulary is limited. It does not include vaginal estradiol rings (Estring), combination estradiol-progesterone formulations (Bijuva), testosterone for hypoactive sexual desire, or compounded bi-est/tri-est preparations that some clinicians prescribe for individualized therapy.

The 2022 Menopause Society position statement affirms that "hormone therapy remains the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause" and recommends individualized regimens based on symptom severity, personal risk factors, and patient preference [6]. A one-size-fits-most formulary can miss the mark for women who need dose adjustments beyond standard patch strengths or who have contraindications to oral progesterone.

Best alternatives for HRT:

• HealthRX provides estradiol (patch, gel, and oral), micronized progesterone, and testosterone therapy for women, with labs (estradiol, FSH, SHBG, lipid panel) ordered before and during treatment. Synchronous video visits allow real-time dose adjustment.
• Evernow is a menopause-focused telehealth platform with board-certified menopause specialists. It offers a broader HRT formulary and includes at-home hormone testing. Monthly pricing ranges from $49 to $175.
• Midi Health specializes in midlife women's health, staffing nurse practitioners and physicians with menopause certification. Visit-based (not subscription-only), it accommodates complex cases including women on tamoxifen or aromatase inhibitors who need non-hormonal vasomotor treatment like fezolinetant (Veozah).
• Local menopause clinics accredited through the Menopause Society remain the gold standard for complex cases, particularly women with a history of breast cancer, VTE, or cardiovascular disease who need careful risk stratification per the 2024 Endocrine Society guidelines [7].

For straightforward vasomotor symptoms in an otherwise healthy woman, Hers may be adequate. For anything requiring lab-driven titration, testosterone, or specialty risk evaluation, a dedicated menopause platform or clinic is the better path.

Hair Loss: Comparing Topical and Oral Options

Hers prescribes topical minoxidil (2% and 5%), spironolactone (off-label for androgenetic alopecia), and in some cases oral minoxidil at low doses. It also offers finasteride off-label for women, though prescribing patterns vary by state and provider.

A 2019 randomized trial in the Journal of the American Academy of Dermatology showed that oral minoxidil 0.25 mg plus spironolactone 25 mg daily improved hair density by 12.7% at 24 weeks in women with female pattern hair loss [8]. Topical minoxidil 5% remains the only FDA-approved over-the-counter treatment for female androgenetic alopecia, with a meta-analysis reporting a mean increase of 13.2 hairs/cm² versus placebo at 24 weeks [9].

Best alternatives for hair loss:

• HealthRX offers oral minoxidil, spironolactone, and topical formulations with dermatology-informed protocols and follow-up labs (potassium for spironolactone, blood pressure for oral minoxidil).
• Happy Head compounds custom topical formulations combining minoxidil, finasteride, and other agents into a single daily application. Pricing starts at $49/month.
• Apostrophe provides dermatologist-led teledermatology with prescription access to spironolactone, topical minoxidil, and tretinoin combination formulas.
• In-person dermatology is necessary for women with scarring alopecias (lichen planopilaris, frontal fibrosing alopecia) or suspected autoimmune hair loss, where biopsy is required before treatment.

Hers is a reasonable starting point for uncomplicated female pattern hair loss. If you need combination compounded topicals, lab monitoring for oral agents, or diagnostic workup, alternatives with synchronous clinical oversight are preferable.

Mental Health: SSRIs, SNRIs, and Beyond

Hers prescribes SSRIs (sertraline, escitalopram, fluoxetine), SNRIs (desvenlafaxine), and buspirone for anxiety. These are first-line agents per the APA Practice Guidelines [10]. The prescribing is handled through asynchronous questionnaire-based encounters.

The limitation is not the medications. It is the follow-up. The APA recommends "follow-up within one to two weeks of initiating or changing an antidepressant to assess tolerability and early response" [10]. A 2022 analysis in Psychiatric Services found that patients using async-only mental health platforms had 40% fewer follow-up contacts in the first 90 days compared to those using synchronous telehealth [11]. Lower follow-up frequency correlates with higher discontinuation rates and unaddressed side effects.

Best alternatives for mental health:

• Talkiatry provides psychiatrist-led synchronous video visits (not just prescribers), accepts most major insurance plans, and handles complex cases including treatment-resistant depression and ADHD comorbidities.
• Cerebral offers therapy-plus-medication packages with scheduled follow-ups. Monthly plans range from $85 (medication only) to $325 (therapy + medication).
• Brightside combines measurement-based care (PHQ-9 and GAD-7 tracking at every visit) with psychiatrist prescribing, which aligns with the APA's recommendation for serial symptom monitoring.
• In-person psychiatry remains necessary for patients who need controlled substances (benzodiazepines, stimulants), those with suicidal ideation requiring safety planning, or individuals with psychotic features.

For stable, uncomplicated anxiety or mild-to-moderate depression where you already know which SSRI works for you, Hers can handle the refill. For new diagnoses, medication changes, or any complexity, synchronous psychiatric care is the clinical standard.

Pricing Comparison Across Use Cases

Cost is a primary reason patients choose D2C platforms over traditional care. Here is how Hers pricing compares to its strongest alternatives in each category as of early 2026.

Weight loss (compounded semaglutide): Hers charges $149 to $199/month. HealthRX starts at $149/month with included physician visits. Ro starts at $145/month with included metabolic labs.

HRT (estradiol patch + progesterone): Hers bundles at approximately $85/month. Evernow ranges from $49 to $175/month depending on the regimen. Midi Health charges per visit ($250 initial, $150 follow-up) plus pharmacy costs.

Hair loss (minoxidil + spironolactone): Hers prices this at $25 to $45/month. Happy Head custom compounds run $49 to $79/month. Apostrophe charges $20 to $75/month depending on the prescription.

Mental health (SSRI): Hers offers generic SSRIs at $25 to $85/month including the consultation fee. Brightside charges $95/month for medication management. Talkiatry bills insurance directly for most patients.

The price differences are real but not dramatic. The meaningful variation is in what you get for that price: async questionnaire versus live physician visit, narrow formulary versus full prescribing flexibility, no labs versus included monitoring.

How to Choose: A Decision Framework

Skip the brand loyalty. Match the platform to the clinical complexity of your situation.

Choose Hers if you need a simple refill of a medication you have already been stabilized on (topical minoxidil, a known SSRI, standard-strength estradiol patch) and your case has no complicating factors.

Choose a specialty alternative if you are starting a new medication, need dose titration, have comorbidities that affect prescribing (cardiovascular disease, history of clotting, liver disease), want access to tirzepatide or brand-name GLP-1s, or need lab monitoring as part of your care.

Choose in-person care if you have a complex psychiatric history, scarring alopecia requiring biopsy, a personal history of hormone-sensitive cancer, or BMI above 40 with obesity-related complications requiring multidisciplinary management.

Dr. Stephanie Faubion, Director of the Mayo Clinic Center for Women's Health and Medical Director of the Menopause Society, has stated: "The best menopause care is individualized care. There is no one-size-fits-all hormone regimen" [6]. That principle applies across every category Hers covers. The right platform is the one that can individualize your treatment, not just ship you a subscription.

A 2024 survey by the Telehealth Research Incubator at the University of Michigan found that 58% of patients using D2C telehealth platforms reported satisfaction with convenience but only 34% felt their care was "as thorough as in-person visits" [12]. Convenience and clinical quality are not the same axis. Know which one matters more for your situation, then choose accordingly.